麻豆原创

1. Executive Summary
2. Research Methodology
3. Radiopharmaceutical
3.1 Overview
3.1.1 麻豆原创 Evolution
3.2 Category
3.3 Applications
3.3.1 Therapeutic Uses
3.3.2 Orthopedics
3.3.3 Oncology
3.3.4 Radiosynoviorthesis
4. 麻豆原创 Analysis
4.1 麻豆原创 Sizing (Actual & Forecasted)
4.2 麻豆原创 Share Analysis
4.2.1 麻豆原创 Share by Products
4.2.2 麻豆原创 Share by Radioisotope
4.2.3 麻豆原创 Share by Source
4.2.4 麻豆原创 Share by Application
4.2.5 麻豆原创 Share by Region
5. 麻豆原创 Segmentation
5.1 Diagnostics
5.1.1 麻豆原创 Sizing (Actual & Forecasted)
5.1.2 麻豆原创 Share by Products
5.2 Therapeutics
5.2.1 麻豆原创 Sizing (Actual & Forecasted)
5.2.2 麻豆原创 Share by Products
6. Regional Analysis
6.1 North America
6.1.1 The US
6.1.1.1 麻豆原创 Sizing (Actual & Forecasted)
6.1.1.2 麻豆原创 Share by Products
6.2 Europe
6.2.1 麻豆原创 Sizing (Actual & Forecasted)
6.2.2 麻豆原创 Share by Products
6.2.3 The UK
6.2.3.1 麻豆原创 Sizing (Actual & Forecasted)
6.2.4 Germany
6.2.4.1 麻豆原创 Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 麻豆原创 Sizing (Actual & Forecasted)
6.3.2 China
6.3.2.1 麻豆原创 Sizing (Actual & Forecasted)
6.3.3 Japan
6.3.3.1 麻豆原创 Sizing (Actual & Forecasted)
7. 麻豆原创 Dynamics
7.1 Industry Trends & Development
7.1.1 Adoption of New Radiopharmaceuticals for Molecular Imaging
7.1.2 Fusion Imaging
7.2 Growth Drivers
7.2.1 Higher Incidence of Chronic Diseases
7.2.2 Prevalence of Cancer and Cardiac Ailments
7.2.3 Increasing Awareness of Radiopharmaceuticals
7.3 Challenges
7.3.1 Stringent Regulatory Norms
7.3.2 Scarcity of Radioisotopes
7.3.3 High Cost of Procedure
8. Competitive Landscape
8.1 Financial Analysis
8.2 麻豆原创 Share by Competitors
9. Company Profiles
9.1 Siemens Healthineers AG
9.2 GE Healthcare
9.3 IBA RadioPharma Solutions
9.4 Lantheus Holdings, Inc.
9.5 Eckert & Ziegler

List of Tables
Table 1: Applications of Radiopharmaceuticals in Healthcare
Table 2: Global Radiopharmaceutical Companies Financial Analysis (2018)

List of Figures
Figure 1: Rockville Research 鈥� Research Methodology
Figure 2: Emission of Radiation from Radionuclide
Figure 3: Global Radiopharmaceutical 麻豆原创 Size by Value, 2010-18E (US$ Billions)
Figure 4: Global Radiopharmaceutical 麻豆原创 Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 5: Global Radiopharmaceutical 麻豆原创 Share by Products (2017)
Figure 6: Global Radiopharmaceutical 麻豆原创 Share by Type of Radioisotope (2017)
Figure 7: Global Radiopharmaceutical 麻豆原创 Share by Source (2017)
Figure 8: Global Radiopharmaceutical 麻豆原创 Share by Application (2017)
Figure 9: Global Radiopharmaceutical 麻豆原创 Share by Region (2017)
Figure 10: Global Radiopharmaceutical 鈥� Diagnostics 麻豆原创 Size by Value, 2012-18E (US$ Billions)
Figure 11: Global Radiopharmaceutical 鈥� Diagnostics 麻豆原创 Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 12: Global Radiopharmaceuticals 鈥� Diagnostics 麻豆原创 Share by Products (2017)
Figure 13: Global Radiopharmaceutical 鈥� Therapeutics 麻豆原创 Size by Value, 2012-18E (US$ Billions)
Figure 14: Global Radiopharmaceutical 鈥� Therapeutics 麻豆原创 Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 15: Global Radiopharmaceuticals 鈥� Therapeutics 麻豆原创 Share by Products (2017)
Figure 16: North America Radiopharmaceutical 麻豆原创 Size by Value, 2015-24E (US$ Billions)
Figure 17: The US Radiopharmaceutical 麻豆原创 Size by Value, 2013-18E (US$ Billions)
Figure 18: The US Radiopharmaceutical 麻豆原创 Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 19: The US Radiopharmaceutical 麻豆原创 Share by Products (Diagnostics/Therapeutics), 2013-24E
Figure 20: Europe Radiopharmaceutical 麻豆原创 Size by Value, 2015-24E (US$ Billions)
Figure 21: Europe Radiopharmaceutical 麻豆原创 Share by Products (2017)
Figure 22: The UK Radiopharmaceutical 麻豆原创 Size by Value, 2015-24E (US$ Millions)
Figure 23: The UK Radiopharmaceutical 麻豆原创 Size by Value, 2015-24E (US$ Millions)
Figure 24: Asia Pacific Radiopharmaceutical 麻豆原创 Size by Value, 2015-24E (US$ Billions)
Figure 25: China Radiopharmaceutical 麻豆原创 Size by Value, 2017-24E (US$ Millions)
Figure 26: Japan Radiopharmaceutical 麻豆原创 Size by Value, 2017-24E (US$ Millions)
Figure 27: Global Chronic Disease Incidences, 2013-17 (Millions)
Figure 28: Global Cancer and Cardiac Disease Incidence, 2012-17 (Millions)
Figure 29: Global Radiopharmaceutical 麻豆原创 Share by Competitors (2017)
Figure 30: Siemens Healthineers AG Revenue by Business Segment (FY2017)
Figure 31: Siemens Healthineers AG Net Sales, FY2013-FY2018 (US$ Billions)
Figure 32: GE Healthcare Revenue by Business Segment (FY2017)
Figure 33: GE Healthcare Net Sales, FY2013-FY2017 (US$ Billions)
Figure 34: IBA Group Revenue by Business Segment (FY2017)
Figure 35: IBA Group Net Sales, FY2013-FY2017 (US$ Millions)
Figure 36: Lantheus Holdings, Inc. revenue by Business Segment (FY2017)
Figure 37: Lantheus Holdings, Inc. Net Sales, FY2013-FY2017 (US$ Millions)
Figure 38: Eckert & Ziegler Revenue by Business Segment (FY2017)
Figure 39: Eckert & Ziegler Net Sales, FY2013-FY2017 (US$ Millions)